NEW YORK, July 21 (GenomeWeb News) - Shares in CombiMatrix were down 10 percent, or $.14, at $1.22 in mid-afternoon trading today after the company reported a decline in revenues for the second quarter.
...and receive Daily News bulletins.
Already have an account?Login Now.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.
In Science this week: in vitro generation of human reproductive cells, and more.